Detalhe da pesquisa
1.
Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study.
CMAJ;
195(46): E1565-E1576, 2023 11 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38011930
2.
Medicine donations: a review of policies and practices.
Global Health;
19(1): 67, 2023 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37658389
3.
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.
J Gen Intern Med;
36(10): 3194-3198, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33694070
4.
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.
CMAJ;
192(23): E617-E625, 2020 06 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32538799
5.
A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016.
Pharmacoepidemiol Drug Saf;
29(9): 1054-1063, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32696556
6.
Therapeutic Value of Orphan Drugs Approved by Health Canada: A Cross-Sectional Study.
J Gen Intern Med;
2024 Feb 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38326584
7.
Secret safety warnings on medicines: A case study of information access requests.
Pharmacoepidemiol Drug Saf;
28(4): 551-555, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30840349
8.
Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.
Global Health;
15(Suppl 1): 78, 2019 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31775767
9.
Medicines Information and the Regulation of the Promotion of Pharmaceuticals.
Sci Eng Ethics;
25(4): 1167-1192, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29721844
10.
Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence.
Global Health;
14(1): 86, 2018 08 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30134929
11.
Les défis du coût de la vie soulignent l'urgence pour les médecins de prescrire des médicaments abordables.
Can Fam Physician;
69(9): 606-608, 2023 09.
Artigo
em Francês
| MEDLINE
| ID: mdl-37704238
12.
Cost-of-living challenges highlight urgency for clinicians to prescribe affordable medications.
Can Fam Physician;
69(9): 599-600, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37704251
13.
The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries.
Glob Soc Policy;
18(1): 7-27, 2018 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29706802
14.
Sponsorship of Canadian Professional Medical Societies by Drug, Medical Device and Medical Technology Companies: a Cross-sectional Study.
J Gen Intern Med;
37(16): 4280-4282, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35476238
15.
Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?
Br J Clin Pharmacol;
83(11): 2549-2556, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28664660
16.
Antidepressants are not safe during pregnancy and in women of child-bearing age.
Br J Clin Pharmacol;
88(5): 2447-2448, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34904264
17.
Market Exclusivity Time for Top Selling Originator Drugs in Canada: A Cohort Study.
Value Health;
20(8): 1139-1142, 2017 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28964446
18.
Pharmaceutical security for Canada.
CMAJ;
194(32): E1113-E1116, 2022 08 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35995443
19.
Developing a Clinician Friendly Tool to Identify Useful Clinical Practice Guidelines: G-TRUST.
Ann Fam Med;
15(5): 413-418, 2017 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28893810
20.
Industry sponsorship and research outcome.
Cochrane Database Syst Rev;
2: MR000033, 2017 02 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28207928